医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: A meta-analysis

广告
第一作者: Cortes,J.
作者单位: Department of Medical Oncology, Mount Vernon Cancer Centre, Middlesex, United Kingdom [1] Department of Medical Oncology, University of Miami Leonard M. Miller School of Medicine, Miami, FL [2] Department of Medical Oncology, Hospital Universitario de Guadalajara, Guadalajara, Spain [3] Department of Medical Oncology, Arnau de Vilanova Hospital, Lérida, Spain [4] Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain [5] Department of Medical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, United [6] Department of Medical Oncology, Baylor-Charles A. Sammons Cancer Center, Texas Oncology, and US [7] Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, United States [8] Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain [9] Department of Medical Oncology, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates [10] Department of Medical Oncology, Virginia Cancer Specialists, US Oncology, Fairfax, VA, United States [11] Department of Medical Oncology, Vall d?Hebron University Hospital, Barcelona, Spain [12]
发布时间 2013-11-20
提交
  • 浏览1
Annals of oncology: official journal of the European Society for Medical Oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷